Evonik has announced that it is expanding its production facilities in Birmingham, Alabama and Darmstadt, Germany that will create additional capacity for the production of biodegradable polymers that are used to manufacture bioresorbable medical devices and controlled-release formulations for parenteral drug delivery.

The expansion will involve construction of a new building adjacent to Evonik’s existing facility in Birmingham. Besides greater production capacity, the project will also result in new production cleanrooms and a laboratory for polymer contract research projects. Commissioning is slated for late 2018.

The Darmstadt unit capacity will also be increased with the opening of a new production line. The company will also open an applied technology laboratory in Darmstadt at the end of 2016 for the medical device field.

Source: Evonik